Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

24.46
Delayed Data
As of Feb 24
 -0.40 / -1.61%
Today’s Change
7.84
Today|||52-Week Range
37.69
+37.96%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close24.86
Today’s open24.83
Day’s range24.05 - 24.83
Volume24,754
Average volume (3 months)32,494
Market cap$153.9M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+30.30%
Earnings growth (this year)+63.04%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.28

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.10+2.53%
OPHTOphthotech Corp-0.02-0.47%
SMMTSummit Therapeutics ...+0.07+0.58%
OCXOncoCyte Corp+0.17+3.39%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ronald H. Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs